共查询到19条相似文献，搜索用时 125 毫秒
1.
为了配合（Porcine reproductive and respiratory syndrome virus, PRRSV）基因标记疫苗株（rHN4-Δ25＋NP49株）的临床抗体鉴别诊断应用,本研究以标记疫苗中缺失的25个氨基酸多肽作为包被抗原,通过对ELISA反应条件的优化,确定抗原最适包被浓度为500 ng/孔,血清最佳稀释度为1：40,同时确定其阴阳性临界值S/P判定标准为0.15,批内和批间重复实验结果显示其变异系数均低于10%,表明该方法具有良好的重复性。对临床血清检测结果显示与IDEXX试剂盒检测结果的符合率为94.84%,采用25 aa负标记ELISA方法检测HuN4-F112免疫猪血清,结果显示从免疫后21 d可检测25 aa特异性抗体,该抗体至少可持续存在126 d。本研究建立的ELISA检测方法为今后PRRSV基因工程标记弱毒疫苗株在临床鉴别诊断的应用提供了有利保障。 相似文献
2.
进行猪繁殖与呼吸综合征（PRRS）疫苗安全及效力试验时,需要选用猪繁殖与呼吸综合征病毒（PRRSV）抗原、抗体均为阴性的猪血清。为此,应用EUSA和RT—PCR方法对取自陕西省关中部分县（区）散养的未进行猪繁殖与呼吸综合征疫苗免疫猪群共计135份血清样品进行了PRRSV抗体和抗原测定。结果表明,PRRSV抗体阳性率为6．67％（9／135）．PRRSV抗体阴性猪群中抗原阳性率为11．11％（14／126）。由此可以得出,该地区农户散养的猪群存在感染猪繁殖与呼吸综合征病毒的危险。 相似文献
3.
乙脑病毒非结构蛋白NS1的原核表达及重组蛋白间接ELISA方法的初步建立 总被引：1，自引：0，他引：1
克隆表达乙脑病毒非结构蛋白NS1,并以其作为包被抗原,建立间接ELISA诊断方法。用此方法分别检测猪繁殖与呼吸综合征病毒(PRRSV)、猪瘟病毒(CSFV)及猪圆环病毒(PCV)阳性血清各3份,以及33份健康非免疫仔猪血清和205份乙型脑炎灭活疫苗免疫的猪血清,评价NS1-ELISA方法的特异性。取54份乙脑病毒感染的猪血清进行NS1-ELISA检测,评价该方法的敏感性。NS1-ELISA检测的特异性为95%,敏感性达90.7%。与商品化试剂盒比较,其符合率达到96.0%。在重复性试验中,NS1-ELISA检测方法重复性较好。本试验为进一步研究不同感染时期NS1抗体水平的差异奠定基础。 相似文献
4.
《中国兽医杂志》2015,(8)
为了建立一种以合成肽为抗原的猪繁殖与呼吸障碍综合征病毒抗体ELISA检测试剂盒,通过多肽序列的筛选、合成及反应原性的鉴定后,将多肽与非蛋白结构多聚体载体进行偶联,利用偶联后的多肽作为抗原,通过方阵滴定确定偶联多肽、血清、HRP的最佳工作浓度以及阴阳性临界值,再以特异性试验、敏感度测定和临床猪血清样本的免疫效果评估等方法进行确证。结果表明,偶联多肽具有良好的反应原性,其最佳包被浓度为0.5μg/m L,血清最佳稀释度为1∶40,HRP最佳稀释度为1∶4 000。本试验建立的猪繁殖与呼吸障碍综合征病毒抗体检测试剂盒可以用于临床猪血清抗体的检测,且该方法特异性好、敏感度高、操作方便省时。 相似文献
5.
为研制特异性敏感性较好的猪繁殖与呼吸综合征病毒(PRRSV)抗体检测方法,更好地实现PRRSV的流行病学监测和诊断,将PRRSV GDr180毒株N蛋白基因序列克隆到p ET32a(+)载体中,在大肠杆菌BL21(DE3)细胞内实现了高效表达,表达形式为可溶性表达,通过Western blot证明表达产物与PRRSV GDr180株阳性血清具有很好的反应原性和特异性。将大肠杆菌表达的N蛋白经过超声、离心、过柱纯化后,作为间接ELISA包被抗原检测血清中的PRRSV抗体,通过对各参数和试剂的优化建立了能检测PRRSV血清抗体的间接ELISA检测方法;对方法的特异性和重复性以及与同类成品试剂盒间的应用效果对比进行了试验。结果表明,研究建立的ELISA抗体检测方法可用于检测猪血清中PRRSV抗体、监测猪繁殖与呼吸综合征的流行情况和评价相关疫苗的免疫效果。 相似文献
6.
将35头40日龄猪繁殖与呼吸综合征病毒(Porcine reproductive and respiratory syndrome virus,PRRSV)、猪瘟病毒(Classical swine fever virus,CSFV)、猪圆环病毒(Porcine circovirus type 2,PCV2)抗原及抗体均为阴性的健康仔猪,随机分成7组,每组5头,命名为XJ1~XJ7组。XJ1~XJ6组分别免疫PRRSV基因工程双标记疫苗rHN4-△25+NP49株,接种剂量分别为102TCID50/头、103TCID50/头、104TCID50/头、105TCID50/头、106TCID50/头和107TCID50/头,XJ7组为对照组,按1mL/头剂量接种DMEM。各试验组在免疫后28 d,用3×104.0TCID50/头剂量感染HP-PRRSV HuN4第5代强毒,疫苗免疫和攻毒后观察和检测各组试验猪的免疫效果。结果表明:攻毒前XJ2-XJ6组PRRSV ELISA抗体在免疫后14 d全部转为阳性,XJ1组在免疫后21 d转为阳性,但维持在较低水平;XJ2-XJ6组针对标记基因NP49的特异性抗体在免疫后28 d转阳性。攻毒后对照组全部发病,且死亡2头,XJ1有4头发病,XJ2-XJ6组无发病和死亡,本研究结果表明PRRSV基因工程双标记疫苗rHN4-△25+NP49株对仔猪提供免疫保护的最小免疫剂量为103TCID50/头。 相似文献
7.
抗PRRSVGP5和M蛋白独特型抗体替代抗原诱导机体产生中和抗体的研究 总被引：1，自引：0，他引：1
制备猪繁殖与呼吸综合征病毒(PRRSV)抗独特型抗体(Ab2),探讨Ab2替代抗原对机体免疫调节作用的研究。用纯化的PRRSV-GP5(GP5-Ab1)蛋白和抗PRRSV-M(M-Ab1)蛋白单抗免疫大白兔,当免疫血清琼扩效价达1:16以上,加强免疫后心脏采血分离血清,分别纯化兔抗PRRSV-GP5IgG(GP5-Ab2)和抗PRRSV-MIgG(M-Ab2)血清,分别用GP5-Ab2、M-Ab2以及GP5-Ab2与M-Ab2混合型三种分别免疫未免PRRS疫苗的小猪,同时设PRRS弱毒苗、灭活苗和空白组作对照,免疫后21d采集猪血清,间接ELISA检测免疫Ab2和PRRS疫苗的猪血清全为阳性,空白组仍然为阴性。经细胞中和试验证明免疫Ab2及PRRS疫苗的猪血清都具有中和抗体,说明Ab2在体内具有替代PRRSV的作用诱导机体产生具有中和效应的中和抗体,从而起到保护机体免受PRRSV的感染作用,为猪繁殖与呼吸综合征病新型疫苗的研究提供了新的思路。 相似文献
8.
9.
安徽省部分地区猪繁殖与呼吸综合征及猪流感的血清学调查 总被引：5，自引：5，他引：5
采集了安徽省南部10个地区79个发病猪场348份猪血清,用ELISA试剂盒检测了血清中猪繁殖与呼吸综合征及H1N2和H3N1亚型猪流感病毒抗体水平.结果表明,10个地区猪血清中PRRSV抗体均为阳性,阳性率为70.4%;6个地区猪血清中H1N1亚型和H3N2亚型猪流感抗体为阳性,但阳性率分别只有3.5%和4.0%.提示在2006年夏季,发生于安徽省南部部分地区的"猪高热病"的原发病之一为猪繁殖与呼吸综合征. 相似文献
10.
CpG ODN对猪繁殖障碍与呼吸道综合征疫苗免疫影响的研究 总被引：4，自引：1，他引：4
以猪繁殖障碍与呼吸道综合征（蓝耳病．PRRS）病毒为模式病毒．以CpG ODN联合猪繁殖障碍与呼吸道综合征灭活疫苗免疫仔猪．通过ELISA法检测猪血清中抗猪繁殖障碍与呼吸道综合征病毒抗体水平，并用MTT法检测猪淋巴细胞白介素-2（IL-2）诱生活性以及淋巴细胞增殖指数（SI）．试验结果表明：CpG ODN能显著提高仔猪的特异性抗体滴度、淋巴细胞IL-2诱生活性以及淋巴细胞增殖反直．证明CpG ODN能显著增强猪对常规灭活病毒疫苗的免疫应答能力。 相似文献
11.
本研究克隆、表达了猪繁殖与呼吸综合征病毒DY株(GenBank:JN864948)的Nsp7α蛋白,并利用Nsp7α作为包被蛋白建立了ELISA检测方法,并对检测条件进行了优化。结果显示,ELISA最佳条件:抗原包被浓度为1μg/mL,血清稀释度为1∶40,封闭液为10%牛血清,酶标二抗工作稀释度为1∶4000,显色时间为37℃反应15 min。用建立的ELISA检测方法和IDEXX ELISA检测试剂盒检测血清样品115份,总符合率为93.91%。本研究中Nsp7α抗体ELISA检测方法的建立,为PRRSV的抗体监测提供了新的技术支持。 相似文献
12.
禽呼肠孤病毒σNS和P17非结构蛋白作为ELISA鉴别诊断抗原的研究 总被引：1，自引：1，他引：0
表达并纯化了禽呼肠孤病毒(ARV)的2个非结构蛋白σNS和P17,并以此作为包被用抗原,分别进行间接ELISA。结果表明,抗原最佳包被浓度分别为9.3μg/mL和11.5μg/mL;一抗血清的稀释度都是1∶200;HRP酶标二抗羊抗鸡IgG稀释度为1∶5 000,初步建立了能检测ARV感染的σNS-ELISA、P17-ELISA方法。以σNS、P17两种蛋白按以上确定的条件同时包被,建立了σNS-P17-ELISA。分别用σNS-ELISA、P17-ELISA及σNS-P17-ELISA对接种过ARV活病毒或灭活疫苗的33份SPF鸡血清进行检测,结果发现以非结构蛋白建立的3种ELISA方法均能区分ARV活病毒感染与灭活疫苗免疫的抗体,进一步对这3种方法进行敏感性、特异性分析比较,表明σNS-P17-ELISA方法能更有效地区分ARV感染与灭活疫苗免疫抗体。 相似文献
13.
Okuda Y Kuroda M Ono M Chikata S Shibata I 《The Journal of veterinary medical science / the Japanese Society of Veterinary Science》2008,70(10):1017-1025
The objective of this study was to evaluate the influences of genetic and antigenic variations in field isolates of porcine reproductive and respiratory syndrome virus (PRRSV) on vaccine efficacy. Four-week-old pigs were vaccinated with a commercial modified live virus vaccine. Four weeks after vaccination, pigs in both the vaccinated group and the non-vaccinated group were challenged intranasally with 10(7) TCID(50) of PRRSV wt-11 (Experiment 1) or PRRSV wt-7 (Experiment 2). Based on genome sequencing of ORF5 and cross neutralization test results, PRRSV wt-11 is similar to the vaccine strain, whereas wt-7 is distinct from the vaccine strain. In the vaccinated challenged groups, clinical signs were less severe, the mean rate of weight gain was greater, and gross lung lesions were less severe when compared with the non-vaccinated challenged groups in both experiments. In Experiment 1, the virus was isolated from serum at 3 days post-challenge, and the mean virus titers in broncho-alveolar lavage fluids (BALF) and tissues were lower in pigs in the vaccinated challenged groups compared with those in the non-vaccinated challenged group. In Experiment 2, virus isolation from serum, BALF and tissues showed no significant differences between the groups. These results suggest that commercial PRRSV vaccine could be effective in reducing clinical disease following a challenge with field isolates of PRRSV. However, with regards to virological protection, the efficacy of the vaccine may be affected by the nature of the PRRSV isolates. 相似文献
14.
重组GP5AB蛋白间接ELISA检测PRRSV抗体方法的研究 总被引：1，自引：0，他引：1
利用GST-GP5AB重组蛋白作为包被抗原,通过反应条件优化,建立了用于检测猪繁殖与呼吸综合征病毒(PRRSV)抗体的间接ELISA方法。抗原最适包被浓度为2μg/mL,最佳封闭液为0.15%BSA,37℃封闭2 h后,再4℃封闭24 h,血清最适稀释度为1∶200,其作用时间为60m in,酶标抗体最适稀释度为1∶20 000,最适作用时间为90 m in,37℃显色10 m in,S/P≥0.284为阳性,S/P≤0.26为阴性,介于二者之间为可疑的判定标准。该抗原与猪其他4种临床症状类似的疾病的阳性血清反应呈阴性。批内和批间重复性试验结果,变异系数均小于7%,表明本方法具有较好的特异性和重复性。应用本方法初步检测了一些疫苗免疫仔猪血清样品,并与重组N蛋白和PRRSV抗原同时进行比较,结果显示3种抗原检测的结果基本一致。 相似文献
15.
Identification and clinical assessment of suspected vaccine-related field strains of porcine reproductive and respiratory syndrome virus 总被引：6，自引：0，他引：6
Mengeling WL Vorwald AC Lager KM Clouser DF Wesley RD 《American journal of veterinary research》1999,60(3):334-340
OBJECTIVE: To determine the origin and clinical relevance of selected strains of porcine reproductive and respiratory syndrome (PRRS) virus (PRRSV). ANIMALS: 38 pigs without antibodies for PRRSV. PROCEDURE: A seemingly uncommon restriction endonuclease digestion site in a commercially available vaccine strain of attenuated PRRSV was tested for its stability and prevalence under defined conditions. Selected field strains of PRRSV, with or without the restriction-site marker, were subsequently tested in pigs for virulence and for their ability to replicate competitively in pigs simultaneously given the vaccine. RESULTS: Under experimental conditions, the restriction-site marker was stable during long-term infection of pigs. It was not detected in any of the 25 field strains of PRRSV that were isolated before use of the vaccine or 21 of 25 field strains that were isolated after use of the vaccine but that, on the basis of previous testing, were believed unrelated to the vaccine strain. Conversely, it was detected in 24 of 25 field strains that were isolated after use of the vaccine and that, on the basis of previous testing, were believed to be direct-line descendants of the vaccine strain. Putative vaccine-related strains caused more pronounced pathologic changes than did the vaccine strain alone, and they predominated during replication in pigs also given the vaccine strain. CONCLUSIONS: In some swine herds, the vaccine strain may have persisted and mutated to a less attenuated form. CLINICAL RELEVANCE: The potential for persistence and mutation of specific strains of virus should be an important consideration when designing vaccination programs involving attenuated PRRSV. 相似文献
16.
Prieto C Alvarez E Martínez-Lobo FJ Simarro I Castro JM 《Veterinary journal (London, England : 1997)》2008,175(3):356-363
The objective of this study was to determine the degree of protection conferred by a Lelystad-like modified live virus (MLV) vaccine against a heterologous wild-type porcine reproductive and respiratory syndrome virus (PRRSV) isolate of the same cluster. For this purpose, fourteen 3-week-old piglets were divided into three groups: Group A pigs were vaccinated with a modified live virus vaccine, Group B pigs were used as positive controls, and Group C pigs as negative controls. Twenty-eight days after the last dose of vaccine, all pigs in Groups A and B were inoculated with the Spanish PRRSV strain 5710. To evaluate efficacy, clinical signs were recorded and the presence of challenge virus was determined by virus isolation in blood samples and nasal swabs collected at various time points post-challenge (p.c.) and in tissue samples collected at necropsy 24 days p.c. After challenge, moderate clinical signs were observed in pigs from Groups A and B. In addition, all vaccinated pigs were viremic at least once, although viremia tended to be more sporadic in this group than in Group B pigs. PRRSV was detected in at least one tissue sample from four out of five pigs from Group A and in all pigs from Group B. The results indicate that the protection conferred by the MLV vaccine used in this study against a closely related virulent strain was only partial. The findings suggest that the degree of genetic homology of ORF5 between MLV vaccine and challenge isolate is not a good predictor of vaccine efficacy. 相似文献
17.
利用猪繁殖与呼吸综合征病毒（porcine reproductive and respiratory syndrome virus,PRRSV）GP5抗原表位串联表达重组蛋白作为包被抗原,建立检测PPRSV抗体的间接ELISA方法。重组蛋白最佳包被浓度为7.5 μg/mL,最佳封闭液为5%脱脂奶粉,37 ℃封闭2 h;血清最适稀释度为1∶100,37 ℃作用2 h;兔抗猪IgG/辣根酶（HRP）（1∶3000）,37 ℃作用2 h;37 ℃避光显色15 min读取D450 nm值。结果经统计学分析得出,S/P值≥0.254为阳性,S/P值≤0.212为阴性。所建立的ELISA方法检测其他5种猪常见病原阳性血清,其D450 nm值均小于0.212。利用建立的ELISA方法对临床免疫勃林格殷格翰猪繁殖与呼吸综合征活疫苗4周后的猪血清70份进行检测,其D450 nm值均大于0.85,表明本研究建立的重组GP5表位蛋白间接ELISA方法可用于临床样品的监测。 相似文献
18.
In Denmark, a porcine reproductive and respiratory syndrome virus (PRRSV) control programme, comprising vaccination of seropositive herds with a live American type PRRSV vaccine, was started in 1996. In several of these herds, spread of vaccine virus from vaccinated 3-18 week old pigs to non-vaccinated sows was demonstrated by the isolation of vaccine virus from fetuses and stillborn piglets. Surprisingly, sows infected with the American type vaccine strain consistently exhibited significantly stronger serological responses towards European type PRRSV than American type PRRSV. In order to elucidate whether the unexpectedly strong serological reaction towards European-type PRRSV in American type PRRSV infected sows was due to a booster reaction, or reactivation of an unrecognized, latent infection in the sows with European type PRRSV, a challenge study with the vaccine was carried out. In this study, the stronger serological response towards European type PRRSV than towards American type PRRSV was reproduced, and reactivation of the previous natural infection with European PRRSV could neither be demonstrated by virus isolation nor by RT-PCR. So, the increase in antibody titers towards European PRRSV in previously European PRRSV infected pigs after challenge with the vaccine strain seems to be the result of a boosting effect on the immune system, induced by the heterologous vaccine PRRSV strain. 相似文献
19.
Lowe JF Zuckermann FA Firkins LD Schnitzlein WM Goldberg TL 《Journal of the American Veterinary Medical Association》2006,228(7):1082-1088
OBJECTIVE: To compare immunologic responses and reproductive outcomes in sows housed under field conditions following controlled exposure to a wild-type strain of porcine reproductive and respiratory syndrome virus (PRRSV strain WTV) or vaccination with a modified-live virus (MLV) vaccine. DESIGN: Randomized controlled trial. ANIMALS: 30 PRRSV-na?ve 10-week-old female pigs. PROCEDURE: Humoral and cell-mediated immune responses were monitored while pigs were held in isolation for 84 days after inoculation with the WTV strain (n = 10), inoculation with the WTV strain and 42 days later vaccination with a killed-virus vaccine (10), or vaccination with an MLV vaccine (10). Reproductive outcomes were measured after pigs were released into the farm herd. RESULTS: Inoculation with the WTV strain, regardless of whether a killed-virus vaccine was subsequently administered, elicited faster and more substantial production of strain-specific neutralizing antibodies, as well as a more rapid generation of interferon-gamma secreting cells, than did vaccination with the MLV vaccine. Despite the enhanced immune responses in pigs inoculated with the WTV strain, animals vaccinated with the MLV vaccine produced a mean of 2.45 more pigs than did sows exposed to the WTV strain, mainly because of a lower rate for failure to conceive. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that current assays of immunity to PRRSV correlate only imperfectly with degree of clinical protection and that the practice of controlled exposure of sows to a circulating PRRSV strain should be reconsidered in light of negative clinical outcomes. 相似文献